103116-0
Cetuximab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Active
Part Description
LP220476-8 Cetuximab
Cetuximab is a monoclonal antibody used to treat advanced squamous cell carcinoma of the head and neck (SCCHN) and metastatic colorectal cancer (mCRC). Cetuximab competes to bind to the epidermal growth factor receptor (EGRF) and then subsequently inhibits tumor growth and metastasis. Cetuximab is used in conjunction with radiation in the treatment of SCCHN. It is also used as the sole therapy for SCCHN in instances of recurrent or metastatic disease where platinum-based therapy was not effective. In patients with mCRC cetuximab is used in combination with irinotecan or by itself in patients who are unable to tolerate irinotecan. PMID: 18034592 Some patients develop treatment-related hypersensitivity to
cetuximab and detection of anti-cetuximab IgE may help physicians identify patients at risk of a severe infusion reaction. PMID: 25471028
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Cetuximab Ab.IgE:
PrThr: Pt: Ser: SemiQn: RAST - Long Common Name
- Cetuximab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
- Short Name
- Cetuximab IgE RAST
- Display Name
- Cetuximab IgE RAST (S) [Presence]
- Consumer Name Alpha Get Info
- Cetuximab allergy test
Part Model Get Info
- Component
- Cetuximab Ab.IgE
LP220406-5
- Analyte
- Cetuximab Ab.IgE
LP220406-5
- Component Numerator
- Cetuximab Ab.IgE
LP220406-5
- Component Numerator Core
- Cetuximab
LP220476-8
- Component Numerator Core Suffix
- Ab.IgE
LP32399-5
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser
LP7567-3
- System Core
- Ser
LP7567-3
- Super System
- NULL
- Scale
- SemiQn
LP436123-6
- Method
- RAST
LP6477-6
Example Answer List: LL1927-4
Source: Wikipedia- Link to External List
- http://en.wikipedia.org/wiki/RAST_test
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| 0 | LA6111-4 | ||
| 1 | LA6112-2 | ||
| 2 or more | LA6113-0 | ||
| 3 | LA6114-8 | ||
| 4 | LA6115-5 | ||
| 5 | LA10137-0 | ||
| 6 | LA10138-8 |
Basic Attributes
- Class
- ALLERGY
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Observation
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Cetuximab IgE: |
| el-GR | Greek (Greece) | Κετουξιμάμπη Ab.IgE: Synonyms: Ab.IgE ALLERGY PrThr Pt RAST Ανοσοσφαιρίνη E Αντίσωμα Ημιποσοτική Κετουξιμάμπη Ορός |
| es-ES | Spanish (Spain) | Cetuximab IgE: Synonyms: Semicuantitativo |
| fr-FR | French (France) | Cetuximab Ac IgE: |
| it-IT | Italian (Italy) | Cetuximab Ab.IgE: Synonyms: anticorpi anti-IgE anticorpo Presenza o Soglia Punto nel tempo (episodio) Risposta agli antigeni Siero Test di radioallergoassorbimento (RAST) |
| nl-NL | Dutch (Netherlands) | cetuximab As.IgE: Synonyms: antistof; |
| zh-CN | Chinese (China) | 西妥昔单抗 抗体.IgE: Synonyms: Ab.IgE; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://